Travera uses a breakthrough technology to measure which cancer drugs work against each individual’s unique cancer cells.
Travera's investors include National Science Foundation, MedTech Innovator.
Travera is headquartered in Cambridge, United States.
Travera uses a breakthrough technology to measure which cancer drugs work against each individual’s unique cancer cells.
Travera is at the Non-equity Assistance stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Travera — Funding & Investors." VCBacked, June 6, 2023, https://www.vcbacked.co/company/travera. Accessed November 12, 2026.
VCBacked. (2023). Travera — Funding & Investors. Retrieved November 12, 2026, from https://www.vcbacked.co/company/travera
{{cite web |title=Travera — Funding & Investors |url=https://www.vcbacked.co/company/travera |website=VCBacked |access-date=November 12, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated
Work at Travera? Request a listing update